Focus on a higher level to drive industrial upgrading-Chuangxin Tongheng signed a new project with Haizheng Pharmaceutical to boost the process of new drug listing.


2018In March 1993, Beijing Chuangxin Tongheng Technology Co., Ltd. and Haizheng Pharmaceutical (Hangzhou) Co., Ltd. formally signed a new project cooperation agreement based on the concept of "cooperation, complementarity and win-win". The total investment of the project is nearly 0.1 billion yuan. The two sides will carry out higher-level cooperation on industrialized preparative liquid chromatography systems, promote the strategy of national medicine innovation and internationalization, and help Haizheng realize the sustainable development of medicine China dream and achieve win-win cooperation.

As a strategic emerging industry that my country will focus on cultivating and developing in the future, the biomedical industry has also entered a stage of rapid growth. Drugs have a great relationship with human health and the improvement of quality of life. Many drugs are affected by purity, and their efficacy cannot be fully utilized., Even produce toxic and side effects. The application of industrial preparative liquid chromatography in the pharmaceutical industry has become the mainstream of drug separation and purification technology.

As a trusted partner of pharmaceutical customers, Chuangxin Tongheng will also take this new project cooperation as an opportunity to implement an innovative development strategy, transform innovative resources into necessary advantages for development, promote the transformation and upgrading of economic development, leapfrog and catch-up, and at the same time provide Haizheng Pharmaceutical with all-round support in the field of biopharmaceutical separation and purification.

Haizheng Pharmaceutical is the leader of China's pharmaceutical industry, and Chuangxin Tongheng is also the leader of work preparation chromatography. Closer cooperation between the two parties can better play their respective advantages, achieve win-win cooperation, and contribute to the development of China's biopharmaceuticals. Important contribution.


About Innovation Tongheng

Beijing Innovation Tongheng Technology Co., Ltd. was established on December 8, 2000. It is a national high-tech enterprise specializing in the research, development, production and sales of liquid chromatographs. The company adheres to the enterprise development tenet of "taking liquid chromatography technology as the core, constantly expanding the application field and meeting the different needs of customers". It is committed to developing chromatographs and material purification equipment for analysis, preparation and industrial-grade needs. In the field of chromatography products, it has become one of the largest research and manufacturing enterprises in China.

At present, the company's products have been widely used in various fields such as drug analysis, food safety, environmental pollution, life sciences, industrial preparation, etc., and continue to provide customers with innovative products and services, and according to the actual needs of customers, they can provide customers with preliminary process exploration and process The pilot scale-up, the overall scheme design and construction of industrial-grade equipment, has become the largest domestic liquid phase preparation equipment research and development, manufacturing and overall solution enterprise.


About Haizheng Pharmaceutical

Zhejiang Haizheng Pharmaceutical Co., Ltd., headquartered in Taizhou City, Zhejiang Province, has more than 9000 employees. In July 2000, "Haizheng Pharmaceutical" A shares were listed on the Shanghai Stock Exchange (stock code: 600267). Haizheng has successively won awards such as "National High-tech Enterprise", the country's first batch of "Innovative Enterprises", and "Technological Innovation Demonstration Enterprises". It has also won the "Top Ten Export-oriented Enterprise Brands", "Top Ten Innovative Enterprise Brands" and "Top 500 National Manufacturing Industry". In 2014, the Fortune China 500 list was listed in the first batch of "three" enterprises in Zhejiang Province. "Haizheng" and "HISUN" are recognized as well-known trademarks in China.

Zhejiang Haizheng Pharmaceutical Co., Ltd. is a top supplier of APIs and preparations at home and abroad. It is mainly engaged in the research, production and marketing of APIs and preparations in the fields of anti-tumor, anti-infection, cardiovascular, endocrine, immunosuppression, antidepressant, orthopedics, etc. Business covers more than 70 countries and regions around the world, and has formed its own characteristics and advantages in the industrialization of characteristic APIs and high-end preparations.